Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Concert Pharmaceuticals, Inc. CNCE

Set alert

Price alert · CNCE

All alert types
8.37 +8.37 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
0
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
0.00
Beta
0.00
Dividend
0.00
Ex-div date
Earnings
Mar 9, 2023
50-d avg
0.00
200-d avg
0.00
1y target
13.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CNCE has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.43 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.3×
FY 2012: -7.8×FY 2013: -26.3×FY 2014: -6.7×FY 2015: 16.6×FY 2016: -4.5×FY 2017: 6.1×FY 2018: -5.2×FY 2019: -2.8×FY 2020: -5.3×FY 2021: -1.3×
FY 2012 5y median -2.8× FY 2021
P/S 3.3×
FY 2012: 12.4×FY 2013: 6.3×FY 2014: 24.6×FY 2015: 6.0×FY 2016: 1315×FY 2017: 4.1×FY 2018: 27.9×FY 2019: 203×FY 2020: 49.9×FY 2021: 3.3×
FY 2012 5y median 27.9× FY 2021
P/B 1.0×
FY 2012: -1.5×FY 2013: -1.4×FY 2014: 3.8×FY 2015: 3.1×FY 2016: 2.7×FY 2017: 3.0×FY 2018: 1.7×FY 2019: 2.2×FY 2020: 3.0×FY 2021: 1.0×
FY 2012 5y median 2.2× FY 2021
P/FCF -2.0×
FY 2012: -5.9×FY 2013: 12.6×FY 2014: -6.9×FY 2015: 18.1×FY 2016: -5.0×FY 2017: 5.7×FY 2018: -5.8×FY 2019: -4.4×FY 2020: -5.7×FY 2021: -2.0×
FY 2012 5y median -4.4× FY 2021
EV/EBITDA 0.2×
FY 2012: -10.0×FY 2013: -54.2×FY 2014: -6.9×FY 2015: 12.0×FY 2016: -3.8×FY 2017: 5.7×FY 2018: -5.1×FY 2019: -2.4×FY 2020: -4.7×FY 2021: 0.2×
FY 2012 5y median -2.4× FY 2021
EV/Sales -0.6×
FY 2012: 13.4×FY 2013: 6.5×FY 2014: 23.9×FY 2015: 4.6×FY 2016: 1082×FY 2017: 3.9×FY 2018: 26.2×FY 2019: 169×FY 2020: 42.2×FY 2021: -0.6×
FY 2012 5y median 26.2× FY 2021
FCF Yield -51.1%
FY 2012: -16.9%FY 2013: 8.0%FY 2014: -14.5%FY 2015: 5.5%FY 2016: -20.2%FY 2017: 17.4%FY 2018: -17.4%FY 2019: -22.6%FY 2020: -17.6%FY 2021: -51.1%
FY 2012 5y median -17.6% FY 2021

Profitability

Gross Margin 100.0%
FY 2012: 100.0%FY 2013: 100.0%FY 2014: 100.0%FY 2015: 100.0%FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%
FY 2012 5y median 100.0% FY 2021
Operating Margin -237.9%
FY 2012: -144.8%FY 2013: -17.4%FY 2014: -356.8%FY 2015: 37.1%FY 2016: -29406.3%FY 2017: 64.4%FY 2018: -529.1%FY 2019: -7336.6%FY 2020: -919.3%FY 2021: -237.9%
FY 2012 5y median -529.1% FY 2021
Net Margin -253.5%
FY 2012: -159.1%FY 2013: -23.8%FY 2014: -369.6%FY 2015: 36.2%FY 2016: -29149.4%FY 2017: 66.5%FY 2018: -533.3%FY 2019: -7180.0%FY 2020: -946.2%FY 2021: -253.5%
FY 2012 5y median -533.3% FY 2021
ROE -73.6%
FY 2012: 19.2%FY 2013: 5.4%FY 2014: -57.8%FY 2015: 18.5%FY 2016: -59.3%FY 2017: 48.7%FY 2018: -33.4%FY 2019: -76.2%FY 2020: -57.0%FY 2021: -73.6%
FY 2012 5y median -57.0% FY 2021
ROIC -51.6%
FY 2012: -61.3%FY 2013: -13.8%FY 2014: -42.0%FY 2015: 17.3%FY 2016: -54.0%FY 2017: 45.1%FY 2018: -30.2%FY 2019: -64.9%FY 2020: -48.4%FY 2021: -51.6%
FY 2012 5y median -48.4% FY 2021
ROA -50.0%
FY 2012: -61.7%FY 2013: -15.2%FY 2014: -37.5%FY 2015: 16.5%FY 2016: -50.5%FY 2017: 45.2%FY 2018: -29.1%FY 2019: -56.3%FY 2020: -46.9%FY 2021: -50.0%
FY 2012 5y median -46.9% FY 2021

Growth (YoY)

Revenue 312.3%
FY 2012: -34.0%FY 2013: 97.7%FY 2014: -66.2%FY 2015: 678.1%FY 2016: -99.7%FY 2017: 82596.0%FY 2018: -92.7%FY 2019: -89.7%FY 2020: 633.7%FY 2021: 312.3%
FY 2012 FY 2021
Operating Income -6.7%
FY 2012: -64.0%FY 2013: 76.3%FY 2014: -593.8%FY 2015: 181.0%FY 2016: -306.4%FY 2017: 281.1%FY 2018: -160.0%FY 2019: -42.2%FY 2020: 8.1%FY 2021: -6.7%
FY 2012 FY 2021
EPS (diluted) 0.0%
FY 2012: -80.2%FY 2013: 70.3%FY 2014: -270.4%FY 2015: 154.5%FY 2016: -309.2%FY 2017: 278.9%FY 2018: -158.8%FY 2019: -35.8%FY 2020: 26.4%FY 2021: 0.0%
FY 2012 FY 2021
Free Cash Flow 20.0%
FY 2012: -46.4%FY 2013: 147.1%FY 2014: -341.5%FY 2015: 172.6%FY 2016: -307.8%FY 2017: 321.2%FY 2018: -149.9%FY 2019: 2.9%FY 2020: -40.0%FY 2021: 20.0%
FY 2012 FY 2021

Financial Health

Current Ratio 9.3×
FY 2012: 3.6×FY 2013: 2.1×FY 2014: 4.4×FY 2015: 21.7×FY 2016: 17.5×FY 2017: 31.9×FY 2018: 20.6×FY 2019: 6.8×FY 2020: 14.0×FY 2021: 9.3×
FY 2012 5y median 14.0× FY 2021
Quick Ratio 9.3×
FY 2012: 3.6×FY 2013: 2.1×FY 2014: 4.4×FY 2015: 21.7×FY 2016: 17.5×FY 2017: 31.9×FY 2018: 20.6×FY 2019: 9.9×FY 2020: 19.2×FY 2021: 9.3×
FY 2012 5y median 19.2× FY 2021
Debt / Equity 0.1×
FY 2012: -0.2×FY 2013: -0.1×FY 2014: 0.1×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.1×
FY 2012 5y median 0.1× FY 2021
Net Debt / EBITDA 1.7×
FY 2012: -0.8×FY 2013: -1.9×FY 2014: 0.2×FY 2015: -3.6×FY 2016: 0.8×FY 2017: -0.3×FY 2018: 0.3×FY 2019: 0.5×FY 2020: 0.9×FY 2021: 1.7×
FY 2012 5y median 0.5× FY 2021
Interest Coverage 0.0×
FY 2012: -10.0×FY 2013: -2.6×FY 2014: -26.6×FY 2015: 80.2×FY 2016: -114×FY 2017: 114×FY 2018: 438×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2012 5y median 0.0× FY 2021

Dividends

Dividend Yield 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31